GENEWIZ genome engineering solutions, including gRNA construct synthesis and long single-stranded DNA of up to 10 kb, are designed to optimize your CRISPR editing workflow for targeted gene correction in the development of in vivo gene therapies.
CELL/VIRUS BANK PRODUCTION
Perform animal safety studies and develop master cell/virus bank.
With sequencing expertise at single-cell resolution, GENEWIZ offers transcriptome and immune repertoire (TCR/BCR) profiling for validating therapeutic targets during discovery and pre-clinical development.
GENEWIZ and Brooks Life Sciences provide the tools to support your project from discovery to FDA approval.
THE GENEWIZ DIFFERENCE
CONTACT GENEWIZ & bROOKS lIFE sCIENCES
GENEWIZ Ph.D. experts available to discuss your project: